Cadila Healthcare informs about press release

17 Mar 2018 Evaluate

Cadila Healthcare has informed about press release dated March 17, 2018 titled, 'Zydus receives final approval from the USFDA for Omeprazole and Sodium Bicarbonate Capsules.'

The above information is a part of company’s filings submitted to BSE



Zydus Lifesciences Share Price

882.75 1.65 (0.19%)
20-Jan-2026 09:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1661.90
Dr. Reddys Lab 1165.00
Cipla 1385.95
Zydus Lifesciences 882.75
Lupin 2173.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×